MZX Masterflex SE
Masterflex SE, together with its subsidiaries, engages in the development and manufacture of connectors and hose systems made of high-performance plastics and fabrics in Germany, Rest of Europe, and internationally. The company offers spiral, clip, film, monolayer, multilayer, co-extruded, and micro-extruded hoses; connectors comprising pressure-resistant connectors; and clamps, manifolds, distributors, drip chambers, and separating membranes under the Masterflex and Masterduct brand names. It also provides fluoropolymer tubing products; thermoplastic extruded hoses under the Novoplast Schlauchtechnik brand name; hoses wound by hand under the Matzen & Timm brand name; and injection moulded parts under the Fleima-Plastic brand name. It serves the medical technology, food, pharmaceutical, laboratory, and biotechnology sectors; the renewable energies, heating, and ventilation sectors; the aviation, rail, and automotive industries; and the mechanical engineering, plastic, semiconductor, and robotics industries. The company was founded in 1987 and is headquartered in Gelsenkirchen, Germany.…
Industry Peers
Specialty ChemicalsKey Statistics
About Masterflex (ETR: MZX)
›
Masterflex (ETR: MZX) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 617 employees.
The shares were at 14.05 EUR on 19 November 2026, up 9.3% over 52 weeks. Its 52-week range is 12.05 EUR to 14.85 EUR: the price is 5.4% below the high and 16.6% above the low.
At a market capitalisation of 135.14M EUR, it trades at 14.2 times trailing earnings and 11.0 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 34.0, a discount of 58% for MZX. It pays a dividend yielding 2.11% (it pays out 30% of its earnings), against a median of 1.76% among the dividend payers in that peer group.
Masterflex reports return on equity of 12.7%, an operating margin of 13.3% and revenue up 5.6% year over year.
Its debt exceeds its cash by 986.00K EUR, a debt-to-equity ratio of 0.22. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 2 analysts cover the stock, with an average rating of Buy; their mean price target of 19.85 EUR is 41.3% above the current price.